InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
1.680
-0.040 (-2.33%)
At close: Oct 5, 2026, 4:00 PM EDT
1.690
+0.010 (0.60%)
After-hours: Oct 5, 2026, 4:11 PM EDT
InflaRx Market Cap
InflaRx has a market cap or net worth of $247.58 million as of October 5, 2026. Its market cap has increased by 131.29% in one year.
Market Cap
247.58M
Enterprise Value
67.43M
1-Year Change
131.29%
Ranking
Category
Stock Price
$1.68
ChartMarket Cap Chart
Since November 8, 2017, InflaRx's market cap has decreased from $351.36M to $247.58M, a decrease of -29.54%. That is a compound annual growth rate of -3.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 247.58M | 261.83% |
| Dec 31, 2025 | 68.42M | -52.95% |
| Dec 31, 2024 | 145.44M | 51.53% |
| Dec 29, 2023 | 95.98M | -29.96% |
| Dec 30, 2022 | 137.03M | -34.85% |
| Dec 31, 2021 | 210.33M | 48.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Palisade Bio | 255.31M |
| Camp4 Therapeutics | 252.27M |
| Q32 Bio | 251.25M |
| Greenwich LifeSciences | 251.14M |
| Sutro Biopharma | 250.62M |
| Sol-Gel Technologies | 249.97M |
| Alector | 245.65M |
| Evommune | 242.07M |